1-3 of 3
Krithika Chennapan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes of Myelofibrosis Patients in the Era of Using JAK2 Inhibitor with Allogeneic-HSCT at the University of Southern California

Vincent Louie Louie Mendiola, Krithika Chennapan, Denaly Chen, Jack Rodman, Amir Ali, Eric Tam, Abdullah Ladha, Karrune Woan, Preet M. Chaudhary, George Yaghmour
Journal: Blood
Blood (2022) 140 (Supplement 1): 12256–12258.
https://doi.org/10.1182/blood-2022-164745
Published: 2022
Journal Articles

Impact of FLT3 Inhibitor-Based Therapies on Outcomes of Acute Myeloid Leukemia (AML) Patients Receiving Allogenic Stem Cell Transplantation: A Retrospective Study

Krithika Chennapan, Karam Ashouri, Anastasia Martynova, Samvel Nazaretyan, Amir Ali, Eric Tam, Abdullah Ladha, Karrune Woan, Preet M. Chaudhary, Imran Siddiqi, George Yaghmour
Journal: Blood
Blood (2022) 140 (Supplement 1): 4823–4824.
https://doi.org/10.1182/blood-2022-163658
Published: 2022
Journal Articles

Updated Outcomes during the Pandemic: Relationship between CD34and CD3 Cell Doses, One-Year Graft-Versus-Relapse-Free-Survival, Graft-Versus-Host Disease, and Overall Survival in Haploidentical Hematopoietic Stem Cell Transplantation Using Post Transplant Cytoxan: A Single Center Experience

Anastasia Martynova, Krithika Chennapan, Jack Rodman, Mindy Hsiao, Abdullah Ladha, Eric Tam, Karrune Woan, Preet M. Chaudhary, George Yaghmour
Journal: Blood
Blood (2021) 138 (Supplement 1): 1773.
https://doi.org/10.1182/blood-2021-152625
Published: 2021